BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24342979)

  • 21. Enhanced natural killer cell binding and activation by low-fucose IgG1 antibody results in potent antibody-dependent cellular cytotoxicity induction at lower antigen density.
    Niwa R; Sakurada M; Kobayashi Y; Uehara A; Matsushima K; Ueda R; Nakamura K; Shitara K
    Clin Cancer Res; 2005 Mar; 11(6):2327-36. PubMed ID: 15788684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysis of pig endothelium by IL-2 activated human natural killer cells is inhibited by swine and human major histocompatibility complex (MHC) class I gene products.
    Itescu S; Artrip JH; Kwiatkowski PA; Wang SF; Minanov OP; Morgenthau AS; Michler RE
    Ann Transplant; 1997; 2(1):14-20. PubMed ID: 9869836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal transplant immunosuppression impairs natural killer cell function in vitro and in vivo.
    Morteau O; Blundell S; Chakera A; Bennett S; Christou CM; Mason PD; Cornall RJ; O'Callaghan CA
    PLoS One; 2010 Oct; 5(10):e13294. PubMed ID: 20967261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV inhibits early signal transduction events triggered by CD16 cross-linking on NK cells, which are important for antibody-dependent cellular cytotoxicity.
    Lichtfuss GF; Meehan AC; Cheng WJ; Cameron PU; Lewin SR; Crowe SM; Jaworowski A
    J Leukoc Biol; 2011 Jan; 89(1):149-58. PubMed ID: 20884651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.
    Borgerding A; Hasenkamp J; Engelke M; Burkhart N; Trümper L; Wienands J; Glass B
    Exp Hematol; 2010 Mar; 38(3):213-21. PubMed ID: 20056126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conversion of stable ABO-incompatible kidney transplant recipients from mycophenolate mofetil with standard exposure calcineurin inhibitors (CNIs) to everolimus with very low exposure CNIs-a short-term pilot study.
    Uchida J; Machida Y; Iwai T; Kuwabara N; Kabei K; Naganuma T; Kumada N; Kawashima H; Nakatani T
    Clin Transplant; 2014 Jan; 28(1):80-7. PubMed ID: 24329776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Compartment-specific expression of natural killer cell markers in renal transplantation: immune profile in acute rejection.
    Dos Santos DC; Campos EF; Saraiva Câmara NO; David DS; Malheiros DM
    Transpl Int; 2016 Apr; 29(4):443-52. PubMed ID: 26615051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells.
    Boyerinas B; Jochems C; Fantini M; Heery CR; Gulley JL; Tsang KY; Schlom J
    Cancer Immunol Res; 2015 Oct; 3(10):1148-1157. PubMed ID: 26014098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of mycophenolate mofetil on donor-specific antibody formation in renal transplantation.
    Lederer SR; Friedrich N; Banas B; Welser G; Albert ED; Sitter T
    Clin Transplant; 2005 Apr; 19(2):168-74. PubMed ID: 15740551
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Immunosuppressive treatment].
    Niaudet P
    Nephrol Ther; 2011 Dec; 7(7):592-8. PubMed ID: 22118788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effects of interferon-gamma on squamous-cell carcinoma of head and neck targets in antibody-dependent cellular cytotoxicity mediated by human natural killer cells.
    Sung MW; Johnson JT; Van Dongen G; Whiteside TL
    Int J Cancer; 1996 May; 66(3):393-9. PubMed ID: 8621263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cryopreservation on effector cells for antibody dependent cell-mediated cytotoxicity (ADCC) and natural killer (NK) cell activity in (51)Cr-release and CD107a assays.
    Mata MM; Mahmood F; Sowell RT; Baum LL
    J Immunol Methods; 2014 Apr; 406():1-9. PubMed ID: 24561308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of HLA disparity, immunosuppressive regimen used, and type of kidney allograft on production of anti-HLA class-I antibodies after transplant and occurrence of rejection.
    Abdelnoor AM; Ajib R; Chakhtoura M; Daouk M; Medawar W; Uwaydah M; Sawah SI; Khauli RB
    Immunopharmacol Immunotoxicol; 2009; 31(1):83-7. PubMed ID: 18752168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
    Wu L; Adams M; Carter T; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB
    Clin Cancer Res; 2008 Jul; 14(14):4650-7. PubMed ID: 18628480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunological aspects of allogeneic and autologous mesenchymal stem cell therapies.
    Hoogduijn MJ; Roemeling-van Rhijn M; Korevaar SS; Engela AU; Weimar W; Baan CC
    Hum Gene Ther; 2011 Dec; 22(12):1587-91. PubMed ID: 21732766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A rapid method for assessment of natural killer cell function after multiple receptor crosslinking.
    Al-Hubeshy ZB; Coleman A; Nelson M; Goodier MR
    J Immunol Methods; 2011 Mar; 366(1-2):52-9. PubMed ID: 21281644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcineurin inhibitor avoidance with daclizumab, mycophenolate mofetil, and prednisolone in DR-matched de novo kidney transplant recipients.
    Asberg A; Midtvedt K; Line PD; Narverud J; Holdaas H; Jenssen T; Reisaeter AV; Johnsen LF; Fauchald P; Hartmann A
    Transplantation; 2006 Jul; 82(1):62-8. PubMed ID: 16861943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-neutralizing epitopes induce robust hepatitis C virus (HCV)-specific antibody-dependent CD56
    Long L; Jia M; Fan X; Liang H; Wang J; Zhu L; Xie Z; Shen T
    Clin Exp Immunol; 2017 Jul; 189(1):92-102. PubMed ID: 28317093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxic T lymphocytes and natural killer cells display impaired cytotoxic functions and reduced activation in patients with alcoholic hepatitis.
    Støy S; Dige A; Sandahl TD; Laursen TL; Buus C; Hokland M; Vilstrup H
    Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G269-76. PubMed ID: 25501547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-class II -DR humanized monoclonal antibody, IMMU-114, blocks allogeneic immune response.
    Park KH; Sawada T; Murakami T; Ishii Y; Yasuo M; Fuchinoue S; Goldenberg DM; Kubota K
    Am J Surg; 2012 Oct; 204(4):527-34. PubMed ID: 22658578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.